指南与共识流行病学与生物统计真实世界研究与卫生经济医学教育与科研方法

改进临床试验注册平台中试验结果的报告与使用:全球实践、障碍与建议

Improving the reporting and use of trial results in clinical trials registries: global practices, barriers, and recommendations.
指南 / 共识 · J Clin Epidemiol · 2025-07-14

该研究采用三部分混合方法,分析2010至2022年间六大注册平台共201265项随机对照试验的结果报告实践,并对注册者与证据使用者开展在线调查,最终由作者组讨论形成建议。结果显示17%(33163项)报告了某种形式结果,注册者86%(194/225)知晓报告可能性但受时间、精力及担心发表干扰阻碍;证据使用者51%(36/70)曾使用注册结果,障碍包括不信任非同行评议数据及定位困难。建议标准化接口、消除误解并增进信任。

要点

  • 2010至2022年六大注册平台共201265项随机对照试验中,17%(33163项)报告了某种形式的结果。
  • 注册者86%(194/225)知晓可报告结果,但时间、精力及担心干扰发表构成障碍。
  • 证据使用者51%(36/70)曾使用注册结果,障碍为不信任非同行评议数据及结果定位困难。

核心结论

  • 注册平台结果报告实践正在增加,改善需更好的基础设施、政策、培训与资金支持;获得充分支持后,注册平台可成为透明高效传播证据、提升研究质量并减少重复的关键工具。

研究设计与样本

  • 三部分混合方法研究:第一部分对2010至2022年间六大注册平台(每个世界卫生组织区域一个)的随机对照试验结果报告实践进行描述性分析,并深入分析报告格式与可及性;第二部分针对试验注册者与证据使用者开展两项独立在线调查;第三部分由作者组讨论形成建议。

主要发现

  • 第一部分样本共201265项随机对照试验,其中17%(33163项)在注册平台报告了某种形式的结果。
  • 子集分析显示63%的已发布结果可在注册记录中获取,64%至98%的结果数据以可复用格式提供。
  • 第二部分中注册者86%(194/225)知晓注册平台结果报告可能性,但时间、精力及担心发表干扰为障碍。
  • 证据使用者中51%(36/70)曾使用注册结果,障碍包括不信任非同行评议数据及难以定位结果。

关键数值与推荐

  • 建议包括标准化注册平台接口、消除误解并增进对注册平台报告结果的信任。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Recent initiatives promoted results reporting on clinical trials registries to improve transparency and reduce publication bias. However, local reports suggest that results reporting on registries is often inadequate, limiting their usefulness for evidence synthesis. We aimed to 1) provide an overview of results reporting practices across clinical trials registries globally, 2) identify barriers and facilitators to reporting and using results from trials registries, and 3) develop recommendations to improve reporting and usability of results in trials registries. STUDY DESIGN AND SETTING: Three-part mixed methods study. Part 1: Descriptive analysis of results reporting practices for randomized controlled trials (RCTs) starting between 2010 and 2022 across six trials registries (one from each World Health Organization region), with an in-depth analysis focusing on reporting formats and accessibility. Part 2: Two separate online surveys targeting trial registrants and evidence users. Part 3: Discussion among author group to generate recommendations. RESULTS: Part 1: Our sample included 201,265 RCTs, with 17% (33,163 trials) reporting some form of results on a registry. A subset showed 63% of posted results accessible in the registry record, with 64% to 98% of results data available in a reusable format. Part 2: 86% (194/225) of registrants were aware of registry results reporting possibilities, but time, effort, and fear of publishing interference were barriers. For evidence users, 51% (36/70) had used registry results, with barriers including mistrust of non-peer-reviewed data and difficulty locating results. Part 3: Recommendations include standardizing registry interfaces, addressing misconceptions, and fostering trust in registry-reported results. CONCLUSION: Results reporting practices on registries are increasing. Improving these requires better infrastructure, policies, training, and funding. With adequate support, registries can become essential for transparent and efficient evidence dissemination, enhancing research quality, and reducing duplication. PLAIN LANGUAGE SUMMARY: Clinical trials registries are online databases where researchers register medical studies and share their status, details, and results. These registries exist globally and allow researchers to track ongoing studies and emerging evidence on a topic. They also enable the public to identify trials they may be interested to participate in. Although regulations require researchers to share study results on registries within a year of study completion, only a fraction of results are currently available. Our project 1) evaluated the reporting of study results across different trials registries, 2) surveyed individuals involved in reporting and using study findings from registries, and 3) developed recommendations to improve availability and usefulness of these results. We found that increasing trust in registry-reported results, improving registry systems (ie, interfaces, processes), and providing better guidance are necessary steps to enhance reporting and use of registry results. Implementing these changes will make it easier to verify study findings, provide accurate guidelines to physicians, and improve patient care.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Kaul T, Damen JA, Seidler AL, et al. Improving the reporting and use of trial results in clinical trials registries: global practices, barriers, and recommendations. J Clin Epidemiol. 2025. PMID: 40669614. doi:10.1016/j.jclinepi.2025.111901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。